Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Role of early viral infections in development of multiple sclerosis.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
The visual pathway as a model to understand brain damage in multiple sclerosis.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
2014 multiple sclerosis therapeutic update.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Update on multiple sclerosis treatments.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Microglia: The constant gardeners.
FDA Approves New Drug to Treat Psoriasis
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Confounding underlies the apparent 'month of birth' effect in multiple sclerosis.

Pages